Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China flag China · Delayed Price · Currency is CNY
6.35
-0.18 (-2.76%)
Nov 13, 2026, 3:00 PM CST

SHA:600222 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
50.916050.5343.56-72.26
Depreciation & Amortization
63.5963.8564.9467.9362.9857.18
Other Amortization
9.549.288.387.774.953.31
Loss (Gain) From Sale of Assets
0.020.02-0.13-0.62-0.07-
Asset Writedown & Restructuring Costs
0.130.13-00.08-0.11.57
Loss (Gain) From Sale of Investments
-1.24-1.24-10.676.4211.876.52
Provision & Write-off of Bad Debts
17.4817.487.0911.8633.8125.54
Other Operating Activities
84.0575.2657.1647.2265.1791.74
Change in Accounts Receivable
-218.71-218.71-91.32-3.07-380.27-130.93
Change in Inventory
9.949.9491.06-7.38-70.61-37.3
Change in Accounts Payable
23.2223.22-196.56-123.27231.5782.8
Operating Cash Flow
46.8647.16-39.5943.74-124.4199.66
Operating Cash Flow Growth
-----35.72%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-16.66-21.12-37.23-43.13-66.62-39.07
Sale of Property, Plant & Equipment
0.050.070.170.220.190.06
Divestitures
-1.490.09-1.80.20.57
Investment in Securities
5.86-17.6749.44-164137.25-87.67
Other Investing Activities
15.8538.85.8855.163.125.96
Investing Cash Flow
3.590.1618.25-150.02134.12-100.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-400----
Long-Term Debt Issued
-1,4811,3681,076950.091,298
Total Debt Issued
1,7641,8811,3681,076950.091,298
Long-Term Debt Repaid
--1,688-1,264-938.41-1,403-1,381
Lease Payments
-14.84-14.84-12.89-16.5-20.75-14.48
Net Debt Issued (Repaid)
374.02193.71103.77137.3-452.6-82.27
Issuance of Common Stock
32.4741.260.0634.46137.1795.16
Repurchase of Common Stock
-8.79-8.79-21.28-42.07-37.66-45.48
Common Dividends Paid
-61.95-50.76-69.07-50.17-63.51-84.56
Other Financing Activities
-579.06-190.78-23.26-52.97331.37-39.44
Financing Cash Flow
-243.31-15.37-9.7826.56-85.23-156.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-192.8631.95-31.11-79.72-75.51-157.08

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
30.226.04-76.820.6-191.0360.58
Free Cash Flow Growth
-----7717.75%
Free Cash Flow Margin
1.77%1.48%-3.96%0.03%-9.74%3.78%
Free Cash Flow Per Share
0.060.05-0.140.00-0.340.11
Levered Free Cash Flow
-169.25303.75-285.12-99.01361.28127.37
Unlevered Free Cash Flow
-159.9338.95-247.84-65.03401.67179.77
Free Cash Flow After Leases
15.3511.19-89.71-15.9-211.7846.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.351.111.60.83.734.54
Cash Income Tax Paid
76.270.6559.0384.459.5351
Change in Working Capital
-177.63-177.63-216.88-140.48-230.82-92.2